image
image
user-login
Patent search/

ADJUVANT EFFECT OF THE TLR1/2 AGONIST DIPROVOCIM SYNERGIZES WITH CHECKPOINT-INHIBITING ANTIBODIES TO ELIMINATE DISEASE

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

ADJUVANT EFFECT OF THE TLR1/2 AGONIST DIPROVOCIM SYNERGIZES WITH CHECKPOINT-INHIBITING ANTIBODIES TO ELIMINATE DISEASE

PCT NATIONAL PHASE APPLICATION

Published

date

Filed on 23 February 2021

Patent Information

Application ID202147007551
Date of Application23/02/2021

Documents

NameDate
202147007551-FORM 18 [29-07-2022(online)].pdf29/07/2022
202147007551.pdf18/10/2021
202147007551-FORM 3 [26-07-2021(online)].pdf26/07/2021
202147007551 Correspondence_Power of Attorney_24-03-2021.pdf24/03/2021
202147007551-FORM-26 [09-03-2021(online)].pdf09/03/2021
202147007551-COMPLETE SPECIFICATION [23-02-2021(online)].pdf23/02/2021
202147007551-DECLARATION OF INVENTORSHIP (FORM 5) [23-02-2021(online)].pdf23/02/2021
202147007551-DRAWINGS [23-02-2021(online)].pdf23/02/2021
202147007551-FORM 1 [23-02-2021(online)].pdf23/02/2021
202147007551-PRIORITY DOCUMENTS [23-02-2021(online)].pdf23/02/2021
202147007551-SEQUENCE LISTING [23-02-2021(online)].txt23/02/2021
202147007551-SEQUENCE LISTING(PDF) [23-02-2021(online)].pdf23/02/2021
earn

Refer a friend